Literature DB >> 9462244

Quantitation in inflammatory pleural disease to distinguish tuberculous and paramalignant from chronic non-specific pleuritis.

V L Capelozzi1, P H Saldiva, L Antonângelo, T S de Carvalho, A Logulo, C R de Carvalho, D Deheinzelin.   

Abstract

AIM: To determine by morphometry if pleural biopsies with the histopathological diagnosis of "non-specific pleuritis", malignant, and tuberculous disease could be distinguished morphologically from those with truly non-specific disease.
METHODS: Each pleural biopsy was reviewed taking into account three compartments of reference: the visceral/parietal mesothelial compartment, the submesothelial screen compartment, and the submesothelial adipose tissue compartment. Normal connective tissue, granulation tissue, fibrocellular proliferation, fibrin, polymorphonuclear cells, mononuclear cells, and mesothelial cells were measured using conventional point counting procedures in terms of the fractional area occupied by each parameter within each compartment of reference. Ranking was carried out on 164 patients, based on their diagnosis: chronic non-specific disease (n = 57), tuberculosis (n = 27), malignant disease (n = 58), and conditions associated with transudative effusions (n = 22).
RESULTS: Stepwise discriminant analysis of the resulting data showed that biopsies from patients with tuberculosis, malignant disease, and chronic non-specific disease could be distinguished between themselves and normal cases. Statistical differences among the four groups were observed for eight morphometric parameters related to components of inflammation and extension throughout the three pleural anatomical compartments. A robust discriminant function permitted an adequate classification of the three groups of disease in 88.41% of the cases. Pleural biopsies with fibrin incorporated within granulation tissue on the submesothelial screen compartment showed 100% specificity for patients with tuberculosis, while mononuclear cells in a band-like infiltrate on the submesothelial adipose tissue compartment showed 93.1% specificity for patients with malignant disease. The truly non-specific pleuritis was characterised by deposits of fibrin in the subpleural compartment and discrete signs of chronic inflammation and reparatory fibrosis on the submesothelial screen.
CONCLUSIONS: Morphometric analysis of pleural biopsies may be a useful supplementary histological procedure to support the diagnosis of pleural tuberculosis and malignant disease.

Entities:  

Mesh:

Year:  1997        PMID: 9462244      PMCID: PMC500319          DOI: 10.1136/jcp.50.11.935

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Blunt-end needle biopsy of pleura and rib.

Authors:  H LEVINE; D W CUGELL
Journal:  Arch Intern Med       Date:  1962-05

Review 2.  State of the art. The pleura.

Authors:  S A Sahn
Journal:  Am Rev Respir Dis       Date:  1988-07

Review 3.  Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.

Authors:  A Herbert
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

Review 4.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

Authors:  H J Gundersen; T F Bendtsen; L Korbo; N Marcussen; A Møller; K Nielsen; J R Nyengaard; B Pakkenberg; F B Sørensen; A Vesterby
Journal:  APMIS       Date:  1988-05       Impact factor: 3.205

5.  Subpleural mononuclear cell infiltration. Significance in the differential diagnosis of pleuritis showing nonspecific histologic findings.

Authors:  N Nagata; Y Kawarada; N Shigematsu; T Ishibashi
Journal:  Chest       Date:  1990-11       Impact factor: 9.410

6.  Diagnostic reliability of needle biopsy of the parietal pleura. A review of 272 biopsies.

Authors:  D D Von Hoff; V LiVolsi
Journal:  Am J Clin Pathol       Date:  1975-08       Impact factor: 2.493

7.  Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.

Authors:  U B Prakash; H M Reiman
Journal:  Mayo Clin Proc       Date:  1985-03       Impact factor: 7.616

8.  The pleuropulmonary manifestations of the postcardiac injury syndrome.

Authors:  T J Stelzner; T E King; V B Antony; S A Sahn
Journal:  Chest       Date:  1983-10       Impact factor: 9.410

9.  Sensitivity, specificity, and predictive values of closed pleural biopsy.

Authors:  R H Poe; R H Israel; M J Utell; W J Hall; D W Greenblatt; M C Kallay
Journal:  Arch Intern Med       Date:  1984-02

10.  Clinical characteristics of the patient with nonspecific pleuritis.

Authors:  W K Leslie; G T Kinasewitz
Journal:  Chest       Date:  1988-09       Impact factor: 9.410

View more
  4 in total

1.  Ultrastructural acute features of active remodeling after chemical pleurodesis induced by silver nitrate or talc.

Authors:  Eduardo H Genofre; Francisco S Vargas; Leila Antonangelo; Lisete R Teixeira; Marcelo A C Vaz; Evaldo Marchi; Vera Luiza Capelozzi
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

2.  Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats.

Authors:  Yglesio Moyses de Souza; Belchor Fontes; Joilson O Martins; Paulina Sannomiya; Glacus S Brito; Riad N Younes; Samir Rasslan
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

3.  Combined evaluation of adenosine deaminase level and histopathological findings from pleural biopsy with Cope's needle for the diagnosis of tuberculous pleurisy.

Authors:  Rodolfo Fred Behrsin; Cyro Teixeira da Silva Junior; Gilberto Perez Cardoso; Jorge Luiz Barillo; Joeber Bernardo Soares de Souza; Elizabeth Giestal de Araújo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy.

Authors:  Gaetano Caramori; Lisa Lasagna; Angelo G Casalini; Ian M Adcock; Paolo Casolari; Marco Contoli; Federica Tafuro; Anna Padovani; Kian Fan Chung; Peter J Barnes; Alberto Papi; Guido Rindi; Giuseppina Bertorelli
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.